Claflin Researchers Helping Close the Gap in Health Disparities Associated with HPV

Keiara Reames is a graduate student and researcher majoring in biotechnology at Claflin

By Gloria S. McCutcheon and Samina N. Assanie-Shivji

Henrietta Lacks is an unsung hero in medical research.  We celebrate her life during Black History Month.  She and her family were poor, and worked on a tobacco farm in the South as had her slave ancestors.  Her cells were taken by researchers/scientists in 1951 at Johns Hopkins University and without her knowledge became one of the most important tools in medicine.  Mrs. Lacks died over 65 years ago, but her HeLa cells were the first “immortal” human cells grown in culture, and they are still alive today.  Thus far in scientific research, HeLa cells provided insight for the development of the polio vaccine, and have uncovered discoveries related to cancer, viruses, the effects of atom bombs, in vitro fertilization, gene mapping, etc.  The cells have been marketed around the globe.  Henrietta Lacks’ family members have not profited from this discovery and could not even afford health insurance.

From Henrietta Lacks’ cells, scientists discovered that the human papillomavirus (HPV) causes Cervical Cancer, the second most common cancer next to breast cancer among women in the United States of America.  Reported in 2018, The American Cancer Society estimates that 13,240 new cases of invasive cervical cancer will be diagnosed and about 4,170 women will die from cervical cancer. In the United State, Hispanic women are most likely to develop cervical cancer, followed by African American, Asians, and Pacific Islanders, and Whites.  HPV is a sexually transmitted infection in both males and females.  HPV is categorized into high-risk (HR) and low-risk (LR) types. Cervical cancer is largely attributable to persistent infection with HR-HPV types. HR-HPV types -16 and -18 are predominantly associated with 70% of cervical cancer cases, whereas two LR-HPV -6 and -11 cause 90% of anogenital wart cases.  Approximately 79 million Americans are infected with HPV, causing vulvar cancer, vaginal cancer, penile cancer, anal cancer and head/neck/oral cancers.

HPV is an infection that is rarely discussed within our society.  Recent studies at Claflin University are in accordance with national studies indicating a low level of knowledge and awareness, as well as widespread misconception regarding sexually transmitted infections, especially HPV, according to research that began in 2011 by Tiffany Rickenbacker.  Research conducted on incoming Freshmen in 2016 resulted in only 55% having heard of HPV, and this increased to 75% after educational training during workshops as reported by Keiara Reames who graduated in Biology in 2017.  Keiara participated in RISE (Research Initiative for Scientific Enhancement) and presented her research at national conferences.  She is currently a graduate student in the Biotechnology Program working toward a Master of Science Degree. Her current research involves detecting cancer-causing genes in HR-HPV and LR-HPV.   She is continuing this research that was initiated by Adia Louden who is currently a graduate student in the Rollins School of Public Health At Emory University. Researchers at Duke University have shown prevalence of certain HPV types in African American women not prevalent in Caucasian women.

There are proven ways to decrease    the incidence of cervical cancer. The HPV vaccination, discovered by using HeLa cells, is used to protect individuals from contracting HPV infections. Gardasil, Gardasil 9 and Cervarix are three available vaccines on the market. Research indicates that both girls and boys should be vaccinated at the age of 11 or 12 years old to prevent future cancer due to certain types of HPV.  Vaccination is administered as three injections over a six- month period at following the times: 0 month, 2 months and 6 months. The Vaccine for Children Program offers vaccines at no cost for eligible children through physicians enrolled in the program. For more information, refer to CDC at  Regular Papanicolaou (Pap) smear screening is encouraged to detect early onset of cervical cancer.

Information on prevention of cervical cancer can be found at the Cervical Cancer Free SC website ( The Public Health Student Alliance at Claflin University leads annual community outreach efforts in educating and promoting awareness about HPV. There is a great need for increased health promotion as we address diseases and conditions associated with HPV and contribute to closing the gap in health disparities with disproportionate incidence in minority populations.

Claflin University is in the third year of a 5-year, $1.3 million federal grant to prepare students to enter PhD programs and conduct research in biomedical and behavioral sciences.  Our research is guided by the principles of bioethics, and we teach our students the importance of conducting research with informed consent by participants.  Graduate students enrolled in Dr. McCutcheon’s research ethics class at Claflin University suggest watching the movie entitled, “The Immortal Life of Henrietta Lacks” starring Oprah Winfrey and for a more detailed version of the science and bioethics, one should read Rebecca Skloot’s book of the same title and rated The New York Times Bestseller.

The described research at Claflin University is supported by National Institute of General Medical Sciences of the National Institutes of Health under Award Number R25GM113740, the Research Initiative for Scientific Enhancement (RISE). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.  Dr. Gloria S. McCutcheon is Principal Investigator; Dr. Samina N. Assanie-Shivji is Co-Investigator.

Leave a Comment